| ID | 1514 | |
| PMID | 15603887 | |
| Year | 2005 | |
| Sequence | ICGIVYWMRRHTQKAP KRIRLPHIRED | |
| Name | gD 332-358 (group 3) | |
| Length | 27 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | not mentioned | |
| Mechanism | T-cell epitope peptide identified from HSV1-gD | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
| Enhancer | PBS (pH 7.3). | |
| Properties of enhancer | Not mentioned | |
| Concentration | 25ul | |
| Incubation time | 21 days | |
| Tissue permeability (value with units) | Induced higher IgA response | |
| Tissue Sample | eye | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C=O)CC(=O)O)CCC(=O)O)CCCNC(=N)N)[C@H] (CC)C)Cc3[nH]cnc3)CCC2)CC(C)C)CCCNC(=N)N)[C@H](CC)C) CCCNC(=N)N)CCCCN)CCC1)C)CCCCN)CCC(=O)N) [C@H](O)C)Cc1[nH]cnc1)CCCNC(=N)N)CCCNC(=N)N) CCSC)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)C(C)C) [C@H](CC)C)CS)[C@H](CC)C | |